Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization

@article{Ly2002HepatitisBS,
  title={Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization},
  author={David Ly and Hal F. Yee and Maria Brezina and Paul Martin and Gary Gitnick and Sammy Saab},
  journal={American Journal of Gastroenterology},
  year={2002},
  volume={97},
  pages={138-141}
}
OBJECTIVE:Hemodialysis patients with hepatitis B surface antigen (HBsAg) are considered to have the hepatitis B virus (HBV) and are segregated to limit transmission. However, transient de novo HBsAg has been identified in hemodialysis patients shortly after vaccination. Our hypothesis is that immunization rather than actual HBV infection is the most common cause of de novo HBsAg among hemodialysis patients.METHODS:We performed a prospective study between January, 1998 and June, 2000 of de novo… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Hemodialysis-associated hepatitis B: Revised recommendations for serologic screening

LA Moyer, MJ Alter, MS. Favero
Semin Liver Dis 1990;3:201–4 • 2002
View 1 Excerpt

The test for hepatitis B surface antigen is transiently positive after vaccination with recombinant vaccine.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 1997

Response to the hepatitis B virus vaccine in haemodialysis patients: influence of malnutrition and its importance as a risk factor for morbidity and mortality.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association • 1996
View 1 Excerpt

Similar Papers

Loading similar papers…